219 related articles for article (PubMed ID: 11174352)
1. The smooth muscle cell membrane during atherogenesis: a potential target for amlodipine in atheroprotection.
Tulenko TN; Sumner AE; Chen M; Huang Y; Laury-Kleintop L; Ferdinand FD
Am Heart J; 2001 Feb; 141(2 Suppl):S1-11. PubMed ID: 11174352
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol, calcium and atherosclerosis: is there a role for calcium channel blockers in atheroprotection?
Tulenko TN; Laury-Kleintop L; Walter MF; Mason RP
Int J Cardiol; 1997 Dec; 62 Suppl 2():S55-66. PubMed ID: 9488196
[TBL] [Abstract][Full Text] [Related]
3. Atheroprotection with amlodipine: cells to lesions and the PREVENT trial. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial.
Tulenko TN; Brown J; Laury-Kleintop L; Khan M; Walter MF; Mason RP
J Cardiovasc Pharmacol; 1999; 33 Suppl 2():S17-22. PubMed ID: 10071259
[TBL] [Abstract][Full Text] [Related]
4. Calcium antagonists and vascular smooth muscle cells in atherogenesis.
Pauletto P; Sartore S; Giuriato L; Scatena M; Tonello M; Scannapieco G; Pessina AC; Dal Palù C
J Cardiovasc Pharmacol; 1992; 19 Suppl 2():S8-16. PubMed ID: 1377310
[TBL] [Abstract][Full Text] [Related]
5. Antiatherosclerotic and antiatherogenic effects of a calcium antagonist plus statin combination: amlodipine and lovastatin.
Orekhov AN; Tertov VV; Sobenin IA; Akhmedzhanov NM; Pivovarova EM
Int J Cardiol; 1997 Dec; 62 Suppl 2():S67-77. PubMed ID: 9488197
[TBL] [Abstract][Full Text] [Related]
6. Calcium channel blockers: do they have pleiotropic effects on atherosclerosis?
Pérez IF
J Hum Hypertens; 2000 Apr; 14 Suppl 1():S96-9. PubMed ID: 10854088
[TBL] [Abstract][Full Text] [Related]
7. Effects of amlodipine on gene expression and extracellular matrix formation in human vascular smooth muscle cells and fibroblasts: implications for vascular protection.
Eickelberg O; Roth M; Block LH
Int J Cardiol; 1997 Dec; 62 Suppl 2():S31-7. PubMed ID: 9488193
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of plaque stabilization for the dihydropyridine calcium channel blocker amlodipine: review of the evidence.
Mason RP
Atherosclerosis; 2002 Dec; 165(2):191-9. PubMed ID: 12417269
[TBL] [Abstract][Full Text] [Related]
9. [Programmed cellular death and atherogenesis: from molecular mechanisms to clinical aspects].
Lesauskaite V; Ivanoviene L; Valanciūte A
Medicina (Kaunas); 2003; 39(6):529-34. PubMed ID: 12829874
[TBL] [Abstract][Full Text] [Related]
10. Influence of serum cholesterol on atherogenesis and intimal hyperplasia after angioplasty: inhibition by amlodipine.
Kahn MB; Boesze-Battaglia K; Stepp DW; Petrov A; Huang Y; Mason RP; Tulenko TN
Am J Physiol Heart Circ Physiol; 2005 Feb; 288(2):H591-600. PubMed ID: 15388506
[TBL] [Abstract][Full Text] [Related]
11. Physical effects of cholesterol on arterial smooth muscle membranes: evidence of immiscible cholesterol domains and alterations in bilayer width during atherogenesis.
Tulenko TN; Chen M; Mason PE; Mason RP
J Lipid Res; 1998 May; 39(5):947-56. PubMed ID: 9610760
[TBL] [Abstract][Full Text] [Related]
12. Calcium antagonists and atherosclerosis.
Schachter M
Int J Cardiol; 1997 Dec; 62 Suppl 2():S9-15. PubMed ID: 9488190
[TBL] [Abstract][Full Text] [Related]
13. Calcium channel blockers and atherosclerosis.
Sowers JR
Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):3-9. PubMed ID: 2220798
[TBL] [Abstract][Full Text] [Related]
14. Antiatherogenic action of nitrendipine in hypercholesterolemic rabbits: changes in aortic macrophage accumulation and smooth muscle cell phenotype.
Pauletto P; Da Ros S; Faggin E; Zanetti G; Pessina AC; Faggiotto A; Sartore S
J Vasc Res; 1996; 33(1):5-12. PubMed ID: 8603127
[TBL] [Abstract][Full Text] [Related]
15. [Effects of calcium antagonists on atherosclerosis progression and intima media thickness].
Zannad F
Drugs; 2000; 59 Spec No 2():39-46. PubMed ID: 11002857
[TBL] [Abstract][Full Text] [Related]
16. Atheroprotective effects of long-acting dihydropyridine-type calcium channel blockers: evidence from clinical trials and basic scientific research.
Mason RP
Cerebrovasc Dis; 2003; 16 Suppl 3():11-7. PubMed ID: 12740551
[TBL] [Abstract][Full Text] [Related]
17. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis.
Clinton SK; Underwood R; Hayes L; Sherman ML; Kufe DW; Libby P
Am J Pathol; 1992 Feb; 140(2):301-16. PubMed ID: 1739124
[TBL] [Abstract][Full Text] [Related]
18. Cellular processes in atherogenesis: potential targets of Ca2+ channel blockers.
Schmitz G; Hankowitz J; Kovacs EM
Atherosclerosis; 1991 Jun; 88(2-3):109-32. PubMed ID: 1654052
[TBL] [Abstract][Full Text] [Related]
19. A nifedipine-sensitive smooth muscle cell population is present in the atherosclerotic rabbit aorta.
Pauletto P; Scannapieco G; Borrione AC; Zanellato AM; Tonello M; Giuriato L; Pessina AC; Palù CD; Sartore S
Arterioscler Thromb; 1991; 11(4):928-39. PubMed ID: 2065044
[TBL] [Abstract][Full Text] [Related]
20. Excess membrane cholesterol alters calcium movements, cytosolic calcium levels, and membrane fluidity in arterial smooth muscle cells.
Gleason MM; Medow MS; Tulenko TN
Circ Res; 1991 Jul; 69(1):216-27. PubMed ID: 2054935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
